People living with mild to moderate dementia, including Alzheimer's disease, may benefit from cognitive stimulation therapy. Cognitive stimulation therapy, often called CST, is a structured program of engaging group activities meant to support thinking, participation, and independence. The National Institute for Health and Care Excellence offers group CST in its NG97 dementia guideline to improve cognition, engagement and independence NICE guideline on dementia assessment and support. It best fits people who can attend, follow group discussion, and take part with others.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What happens in a standard CST course?
- What improvements have studies reported?
- How large and lasting are the gains?
- What should families ask care providers?
What happens in a standard CST course?
University College London Faculty of Brain Sciences describes the standard course as 14 sessions over 7 weeks evidence summary for the CST intervention. Sessions run twice weekly and last 45 minutes. Groups are small, usually 5 to 8 people living with dementia.
The short, regular schedule keeps attendance manageable for many families. The small size gives each person room to speak, listen, and join in. Participation itself is part of the support.
What improvements have studies reported?
University College London Faculty of Brain Sciences reports a 201-person multicentre randomised trial that compared CST with usual care. Scores improved on the Mini-Mental State Examination, a brief thinking test. Scores also improved on ADAS-Cog, another cognition measure, and on Quality of Life-Alzheimer's Disease scores. Woods and colleagues found moderate-quality evidence for a small cognition benefit in a 2023 Cochrane review of 37 trials with 2,766 participants Cochrane review of cognitive stimulation for dementia.
The standardized mean difference was 0.40, with median age 79.7. That means thinking improved a little on average, not sharply. Alzheimer Europe, reporting the same Cochrane evidence, notes probable benefits beyond cognition. These include better well-being, mood, daily abilities, communication, and social interaction. For families, clearer conversation and steadier daily routines may matter as much as test scores.
How large and lasting are the gains?
The Cochrane authors describe the reported benefits as generally small and short-term. Effects varied greatly between studies. The same evidence base offers insufficient proof for long-term or comparative effectiveness.
That pattern is common in dementia care research. A small average gain can still mean a noticeable change for one person and little change for another. Readers should view CST as added support, not as treatment that slows Alzheimer's itself.
What should families ask care providers?
University College London Faculty of Brain Sciences points families toward services with trained staff and weekly maintenance sessions. Ask for the schedule, group size, staff training, and cost in writing. Then check whether the meeting time, travel, and group setting suit the person.
- Does trained staff deliver group CST for mild to moderate dementia?
- Is the course the standard 14-session format in a small group?
- Are weekly maintenance sessions offered to help sustain quality-of-life gains?





